Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Merck & Co. presents HIV integrase inhibitors

June 26, 2018

Biktarvy approved in Europe for the treatment of HIV-1 infection

June 26, 2018

Researchers present primary efficacy data on PRO-140 from CD02 study

June 22, 2018

Apabetalone reverses HIV-1 latency and induces apoptosis of reservoir cells

June 12, 2018

HIV-1 fusion peptide targeting, a promising vaccination strategy eliciting neutralizing antibodies

June 12, 2018

European Commission approves Juluca for HIV-1

May 22, 2018

Idenix Pharmaceuticals and Merck identify HIV-1 inhibitors

May 17, 2018

FDA approves Truvada to reduce risk of HIV-1 infection in adolescents

May 16, 2018

Inovio reports new data from phase I study of HIV vaccine Pennvax-GP

May 16, 2018

Hetero Labs divulges betulinic acid analogues for HIV infection

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026